|
Your search for [author]Cellona, R. V. returned 17 records. |
|
|
Sort by:
|
|
|
|
|
|
|
|
Evaluation of four semi-synthetic Mycobacterium leprae antigens with sera from healthy populations in endemic and non-endemic areas.
by Cellona, RolandV.;
Subject: ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EVALUATION STUDIES AS TOPIC; GLYCOLIPIDS; IMMUNOGLOBULIN M; LEPROSY; MYCOBACTERIUM LEPRAE.
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term efficacy of 2 year WHO multiple drug therapy (MDT) in multibacillary (MB) leprosy patients.
by Cellona, RolandV.;
Subject: DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; LEPROSTATIC AGENTS; LEPROSY.
|
|
|
|
|
|
|
|
|
|
|
|
|
A Systems approach to the evolution of education in Ghana.
by Cellona, Dolores C.; 1979.
Subject: Education -- Ghana -- History; Education -- Ghana -- Aims and objectives.
|
|
|
|
|
|
|
|
|
|
|
|
|
Presses and needs of students and attitude of parents in three secondary schools in a rural setting, school year : 1989-1990.
by Cellona, Mercedes B.; 1990.
Subject: High schools; High school students.
|
|
|
|
|
|
|
|
|
|
|
|
|
The efficacy of a four-week, ofloxacin-containing regimen compared with standard who-mdt in PB leprosy.
by Balagon , MF;
Subject: DAPSONE; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; LEPROSTATIC AGENTS; LEPROSY, PAUCIBACILLARY; OFLOXACIN; RECURRENCE; RIFAMPIN; SKIN; TIME FACTORS; TREATMENT OUTCOME; COMBINATION DRUG THERAPY.
|
|
|
|
|
|
|
|
|
|
|
|
|
Prospective study of serological conversion as a risk factor for development of leprosy among household contacts.
by Klatser, PR;
Subject: ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; DISEASE TRANSMISSION, INFECTIOUS; FAMILY CHARACTERISTICS; GLYCOLIPIDS; INCIDENCE; LEPROSY; MYCOBACTERIUM LEPRAE; PROSPECTIVE STUDIES; RISK FACTORS; SEROLOGIC TESTS.
|
|
|
|
|
|
|
|
|
|
|
|
|
Cosmetic intolerance syndrome in a Filipino woman: A case report.
by Encarnacion, Lonabel A;
Subject: COSMETIC INTOLERANCE.
|
|
|
|
|
|
|
|
|
|
|
|
|
Primary dapsone resistance in Cebu, the Philippines; cause for concern.
by Walsh, GeraldP.;
Subject: DAPSONE; DRUG RESISTANCE, MICROBIAL; LEPROSTATIC AGENTS; LEPROSY; MYCOBACTERIUM LEPRAE; PREVALENCE.
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term relapse risk of multibacillary leprosy after completion of 2 years of multiple drug therapy (WHO-MDT) in Cebu, Philippines.
by Walsh, Douglas S.;
Subject: DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; LEPROSTATIC AGENTS; LEPROSY; MYCOBACTERIUM LEPRAE; RECURRENCE; TIME FACTORS; MULTIPLE DRUG THERAPY.
|
|
|
|
|
|
|
|
|
|
|
|
|
Parallel assessment of 24 monthly doses of rifampin, ofloxacin, and minocycline versus two years of World Health Organization multi-drug therapy for multi-bacillary leprosy.
by Walsh, Douglas S.;
Subject: CLOFAZIMINE; DAPSONE; DRUG THERAPY, COMBINATION; LEPROSTATIC AGENTS; LEPROSY; MINOCYCLINE; OFLOXACIN; RIFAMPIN.
|
|
|
|
|
|
|
|
|
|
« Previous 1 2 Next » |